Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation
Samuel A. Stoner(Moores Cancer Center), Dong‐Er Zhang(University of California San Diego), Takahiro Shima(Moores Cancer Center), Catriona Jamieson(La Jolla Alcohol Research), Rafael Bejar(UC San Diego Health System), Ming Yan(Shanghai Jiao Tong University), Huan‐You Wang(University of California San Diego), Katherine Liu(Rutgers, The State University of New Jersey), D. T. Johnson(Memorial Hermann), Kei‐ichiro Arimoto(University of California San Diego), Kun‐Liang Guan(Westlake University)
Cited by 20
Related Papers
mTOR: a pharmacologic target for autophagy regulation
|Journal of Clinical Investigation|2015|2.1k
Mechanisms of Hippo pathway regulation
|Genes & Development|2016|1.7k
Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
|New England Journal of Medicine|2004|1.5k
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
The Hippo pathway: regulators and regulations
|Genes & Development|2013|1.2k